ArticleTherapeutic advances in respiratory disease

Mepolizumab for eosinophilic COPD with frequent exacerbations: single-centre real-world experience in a phenotype-directed approach.

Irena Šarc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.